We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXXI
2301
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $499K | ﹤0.01% |
137,137
+7,200
| +6% | +$25.1K |
|
2302
Financial Institutions
FISI
$827M
| $498K | ﹤0.01% |
21,698
+900
| +4% | +$20.8K |
|
|
HVB
2303
DELISTED
HUDSON VY HLDG CORP
HVB
| $497K | ﹤0.01% |
19,445
-600
| -3% | -$15.4K |
|
|
BNCL
2304
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $496K | ﹤0.01% |
43,917
-2,108
| -5% | -$23.4K |
|
|
SYT
2305
DELISTED
Syngenta Ag
SYT
| $496K | ﹤0.01% |
7,317
+587
| +9% | +$39.5K |
|
2306
Travere Therapeutics
TVTX
$5.89B
| $495K | ﹤0.01% |
20,663
+3,000
| +17% | +$45.7K |
|
|
IQNT
2307
DELISTED
Inteliquent, Inc.
IQNT
| $495K | ﹤0.01% |
31,463
+5,175
| +20% | +$88.5K |
|
|
RLD
2308
DELISTED
REALD INC COM STK
RLD
| $495K | ﹤0.01% |
38,715
+4,775
| +14% | +$57.3K |
|
2309
Inovio Pharmaceuticals
INO
$69.6M
| $494K | ﹤0.01% |
5,041
+875
| +21% | +$84.8K |
|
|
OLP
2310
One Liberty Properties
OLP
$527M
| $494K | ﹤0.01% |
20,226
+900
| +5% | +$21.8K |
|
2311
John B. Sanfilippo & Son
JBSS
$976M
| $492K | ﹤0.01% |
11,416
+700
| +7% | +$27.1K |
|
2312
NMI Holdings
NMIH
$3.31B
| $491K | ﹤0.01% |
65,501
+3,840
| +6% | +$30K |
|
|
PERY
2313
DELISTED
Perry Ellis International Inc
PERY
| $491K | ﹤0.01% |
21,197
+150
| +0.7% | +$3.59K |
|
|
ESPR
2314
DELISTED
Esperion Therapeutics
ESPR
| $490K | ﹤0.01% |
+5,290
| New | +$341K |
|
|
BNCN
2315
DELISTED
BNC Bancorp
BNCN
| $489K | ﹤0.01% |
26,991
+1,500
| +6% | +$25.2K |
|
2316
CRA International
CRAI
$1.14B
| $487K | ﹤0.01% |
15,648
+600
| +4% | +$18.2K |
|
|
GOOD
2317
Gladstone Commercial Corp
GOOD
$625M
| $486K | ﹤0.01% |
26,132
+4,125
| +19% | +$73.6K |
|
|
TLMR
2318
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $486K | ﹤0.01% |
31,755
+10,850
| +52% | +$153K |
|
|
CBR
2319
DELISTED
CIBER Inc.
CBR
| $484K | ﹤0.01% |
117,503
+5,900
| +5% | +$22K |
|
2320
Park-Ohio Holdings
PKOH
$670M
| $483K | ﹤0.01% |
9,178
+1,725
| +23% | +$95.8K |
|
|
VA
2321
DELISTED
Virgin America Inc.
VA
| $483K | ﹤0.01% |
15,880
+3,350
| +27% | +$120K |
|
2322
Carriage Services
CSV
$587M
| $479K | ﹤0.01% |
20,057
+500
| +3% | +$11.3K |
|
|
TBHC
2323
DELISTED
The Brand House Collective
TBHC
| $479K | ﹤0.01% |
20,174
+900
| +5% | +$21.6K |
|
|
OKSB
2324
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $479K | ﹤0.01% |
26,903
+500
| +2% | +$8.25K |
|
|
WSR
2325
DELISTED
Whitestone REIT
WSR
| $478K | ﹤0.01% |
30,116
+1,600
| +6% | +$25.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.